SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-017454
Filing Date
2020-08-04
Accepted
2020-08-04 16:49:04
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10014038_10q.htm 10-Q 838815
2 EXHIBIT 31.1 brhc10014038_ex31-1.htm EX-31.1 12247
3 EXHIBIT 31.2 brhc10014038_ex31-2.htm EX-31.2 12255
4 EXHIBIT 32.1 brhc10014038_ex32-1.htm EX-32.1 5393
5 EXHIBIT 32.2 brhc10014038_ex32-2.htm EX-32.2 5446
  Complete submission text file 0001140361-20-017454.txt   5189127

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aqst-20200630.xml EX-101.INS 813719
7 XBRL TAXONOMY EXTENSION SCHEMA aqst-20200630.xsd EX-101.SCH 56507
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20200630_cal.xml EX-101.CAL 56777
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20200630_def.xml EX-101.DEF 262892
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20200630_lab.xml EX-101.LAB 708112
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20200630_pre.xml EX-101.PRE 405499
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 201073949
SIC: 2834 Pharmaceutical Preparations